Business
Regeneus Ltd (ASX: RGS) a clinical-stage regenerative medicine company, has come to a mutual agreement with Japan-based manufacturer AGC Inc (AGC) to terminate their exclusive manufacturing licence and joint venture agreement.
ASX:RGS - Regeneus AGC Agreement termination paves way for commercial partner
Share:
Listens: 0